Madison Avenue Partners »

Keros Therapeutics shares owned by Madison Avenue Partners

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Madison Avenue Partners from 13F filings

Historical chart of Madison Avenue Partners investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Madison Avenue Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Madison Avenue Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $43M 2.7M 15.82
2025-06-30 $36M 2.7M 13.35

More positions owned by Madison Avenue Partners

Graham Hldgs Com Cl B (GHC)
Sandisk Corp (SNDK)
Markel Corporation (MKL)
Indivior Ord (INDV)
Globus Med Cl A (GMED)
Solventum Corp Com Shs (SOLV)
Theravance Biopharma (TBPH)
Galapagos Nv Spon Adr (GLPG)
British Amern Tob Sponsored Adr (BTI)
Wiley John & Sons Cl A (WLY)
Stagwell Com Cl A (STGW)
News Corp Cl A (NWSA)
Keros Therapeutics (KROS)
Magnera Corp Com Shs (MAGN)
Apartment Invt & Mgmt Cl A (AIV)

View all positions for Madison Avenue Partners

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics